Cardiac Rhythm Disturbances

Carlos R. Manrique, N. Tiwari, J. C. Plana

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Advancements in the early detection and effective treatment of cancer have led to a significant decline in mortality among cancer patients. The resultant improvement in survival brings new challenges such as the recognition and management of arrhythmias as a result of the neoplasia or its treatment. The exact prevalence and incidence of cancer-related arrhythmia are unknown. There could be several plausible explanations for it, such as the absence of cardiac monitoring as part of the old chemotherapy trials, exclusion of cancer patients in cardiology trials, the exclusion of patients at higher risk of developing cardiotoxicity from oncology trials, and the combination of different chemotherapy regimens or chemotherapy along with radiation. In this chapter, we discuss the various cardiac rhythm disturbances arising from cancer as well as secondary to chemotherapy or radiotherapy.

Original languageEnglish (US)
Title of host publicationAnticancer Treatments and Cardiotoxicity
Subtitle of host publicationMechanisms, Diagnostic and Therapeutic Interventions
PublisherElsevier Inc.
Pages95-103
Number of pages9
ISBN (Print)9780128025093
DOIs
StatePublished - Dec 6 2016

Fingerprint

Neoplasms
Drug Therapy
Cardiac Arrhythmias
Combination Drug Therapy
Cardiology
Radiotherapy
Radiation
Survival
Mortality
Incidence
Therapeutics
Cardiotoxicity

Keywords

  • Cardiac
  • Disturbances
  • Rhythm

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Manrique, C. R., Tiwari, N., & Plana, J. C. (2016). Cardiac Rhythm Disturbances. In Anticancer Treatments and Cardiotoxicity: Mechanisms, Diagnostic and Therapeutic Interventions (pp. 95-103). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-802509-3.00013-3

Cardiac Rhythm Disturbances. / Manrique, Carlos R.; Tiwari, N.; Plana, J. C.

Anticancer Treatments and Cardiotoxicity: Mechanisms, Diagnostic and Therapeutic Interventions. Elsevier Inc., 2016. p. 95-103.

Research output: Chapter in Book/Report/Conference proceedingChapter

Manrique, CR, Tiwari, N & Plana, JC 2016, Cardiac Rhythm Disturbances. in Anticancer Treatments and Cardiotoxicity: Mechanisms, Diagnostic and Therapeutic Interventions. Elsevier Inc., pp. 95-103. https://doi.org/10.1016/B978-0-12-802509-3.00013-3
Manrique CR, Tiwari N, Plana JC. Cardiac Rhythm Disturbances. In Anticancer Treatments and Cardiotoxicity: Mechanisms, Diagnostic and Therapeutic Interventions. Elsevier Inc. 2016. p. 95-103 https://doi.org/10.1016/B978-0-12-802509-3.00013-3
Manrique, Carlos R. ; Tiwari, N. ; Plana, J. C. / Cardiac Rhythm Disturbances. Anticancer Treatments and Cardiotoxicity: Mechanisms, Diagnostic and Therapeutic Interventions. Elsevier Inc., 2016. pp. 95-103
@inbook{155b604e4f74404687ce927c77b3dec0,
title = "Cardiac Rhythm Disturbances",
abstract = "Advancements in the early detection and effective treatment of cancer have led to a significant decline in mortality among cancer patients. The resultant improvement in survival brings new challenges such as the recognition and management of arrhythmias as a result of the neoplasia or its treatment. The exact prevalence and incidence of cancer-related arrhythmia are unknown. There could be several plausible explanations for it, such as the absence of cardiac monitoring as part of the old chemotherapy trials, exclusion of cancer patients in cardiology trials, the exclusion of patients at higher risk of developing cardiotoxicity from oncology trials, and the combination of different chemotherapy regimens or chemotherapy along with radiation. In this chapter, we discuss the various cardiac rhythm disturbances arising from cancer as well as secondary to chemotherapy or radiotherapy.",
keywords = "Cardiac, Disturbances, Rhythm",
author = "Manrique, {Carlos R.} and N. Tiwari and Plana, {J. C.}",
year = "2016",
month = "12",
day = "6",
doi = "10.1016/B978-0-12-802509-3.00013-3",
language = "English (US)",
isbn = "9780128025093",
pages = "95--103",
booktitle = "Anticancer Treatments and Cardiotoxicity",
publisher = "Elsevier Inc.",
address = "United States",

}

TY - CHAP

T1 - Cardiac Rhythm Disturbances

AU - Manrique, Carlos R.

AU - Tiwari, N.

AU - Plana, J. C.

PY - 2016/12/6

Y1 - 2016/12/6

N2 - Advancements in the early detection and effective treatment of cancer have led to a significant decline in mortality among cancer patients. The resultant improvement in survival brings new challenges such as the recognition and management of arrhythmias as a result of the neoplasia or its treatment. The exact prevalence and incidence of cancer-related arrhythmia are unknown. There could be several plausible explanations for it, such as the absence of cardiac monitoring as part of the old chemotherapy trials, exclusion of cancer patients in cardiology trials, the exclusion of patients at higher risk of developing cardiotoxicity from oncology trials, and the combination of different chemotherapy regimens or chemotherapy along with radiation. In this chapter, we discuss the various cardiac rhythm disturbances arising from cancer as well as secondary to chemotherapy or radiotherapy.

AB - Advancements in the early detection and effective treatment of cancer have led to a significant decline in mortality among cancer patients. The resultant improvement in survival brings new challenges such as the recognition and management of arrhythmias as a result of the neoplasia or its treatment. The exact prevalence and incidence of cancer-related arrhythmia are unknown. There could be several plausible explanations for it, such as the absence of cardiac monitoring as part of the old chemotherapy trials, exclusion of cancer patients in cardiology trials, the exclusion of patients at higher risk of developing cardiotoxicity from oncology trials, and the combination of different chemotherapy regimens or chemotherapy along with radiation. In this chapter, we discuss the various cardiac rhythm disturbances arising from cancer as well as secondary to chemotherapy or radiotherapy.

KW - Cardiac

KW - Disturbances

KW - Rhythm

UR - http://www.scopus.com/inward/record.url?scp=85027284983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027284983&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-802509-3.00013-3

DO - 10.1016/B978-0-12-802509-3.00013-3

M3 - Chapter

AN - SCOPUS:85027284983

SN - 9780128025093

SP - 95

EP - 103

BT - Anticancer Treatments and Cardiotoxicity

PB - Elsevier Inc.

ER -